CD20 Protein Expression and Anti CD 20 Therapy in Lymphoma Cancer

Book focus to determine the CD20 protein expression in B-cell lymphoma cancer. The aim and objective are as follows: To study the incidence of CD20 in B-cell lymphoma. To evaluate expression of CD20 protein on paraffin embedded tissue sections by Immunohistochemical analysis in B-cell lymphoma. Immunohistochemical analysis is advantageous because the antigen expression can be studied within the cancer cells. To correlate CD20 expression with established clinico-pathological parameters, and understanding antiCD20 therapy on B-cell lymphoma patients. It was assumed that data from the present study would provide better insight in to the role of CD20 in B-cell lymphoma patients, and further help in treatment planning of these patients.